As of 2025-07-19, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (4,006.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.31 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -1303835.9%.
The range of the Relative Valuation is (2,833.84) - (4,737.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 24.2x | 18.3x |
| Forward P/E multiples | 12.1x - 20.2x | 15.8x |
| Fair Price | (2,833.84) - (4,737.16) | (4,006.38) |
| Upside | -922273.3% - -1541643.5% | -1303835.9% |
| Date | P/E |
| 2025-07-16 | -0.00 |
| 2025-07-15 | -0.00 |
| 2025-07-14 | -0.00 |
| 2025-07-11 | -0.00 |
| 2025-07-10 | -0.00 |
| 2025-07-09 | -0.00 |
| 2025-07-08 | -0.00 |
| 2025-07-07 | -0.00 |
| 2025-07-03 | -0.00 |
| 2025-07-02 | -0.00 |
| 2025-07-01 | -0.00 |
| 2025-06-30 | -0.00 |
| 2025-06-27 | -0.00 |
| 2025-06-26 | -0.00 |
| 2025-06-25 | -0.00 |
| 2025-06-24 | -0.00 |
| 2025-06-23 | -0.00 |
| 2025-06-20 | -0.00 |
| 2025-06-18 | -0.00 |
| 2025-06-17 | -0.00 |
| 2025-06-16 | -0.00 |
| 2025-06-13 | -0.00 |
| 2025-06-12 | -0.00 |
| 2025-06-11 | -0.00 |
| 2025-06-10 | -0.00 |
| 2025-06-09 | -0.00 |
| 2025-06-06 | -0.00 |
| 2025-06-05 | -0.00 |
| 2025-06-04 | -0.00 |
| 2025-06-03 | -0.00 |
| 2025-06-02 | -0.00 |
| 2025-05-30 | -0.00 |
| 2025-05-29 | -0.00 |
| 2025-05-28 | -0.00 |
| 2025-05-27 | -0.00 |
| 2025-05-23 | -0.00 |
| 2025-05-22 | -0.00 |
| 2025-05-21 | -0.00 |
| 2025-05-20 | -0.00 |
| 2025-05-19 | -0.00 |
| 2025-05-16 | -0.00 |
| 2025-05-15 | -0.00 |
| 2025-05-14 | -0.00 |
| 2025-05-13 | -0.00 |
| 2025-05-12 | -0.00 |
| 2025-05-09 | -0.00 |
| 2025-05-08 | -0.00 |
| 2025-05-07 | -0.00 |
| 2025-05-06 | -0.00 |
| 2025-05-05 | -0.00 |